OIM
EPZM

Oracle Investment Management’s Epizyme, Inc EPZM Stock Holding History

Oracle Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28,884
Closed -$306K – 22
2018
Q3 		$306K Sell
28,884
-98,259
-77% -$1.12M 0.07% 17
2018
Q2 		$1.72M Sell
127,143
-269,182
-68% -$4.19M 0.42% 17
2018
Q1 		$7.04M Buy
396,325
+33,433
+9% +$565K 1.7% 12
2017
Q4 		$4.55M Sell
362,892
-6,511
-2% -$94.6K 0.9% 13
2017
Q3 		$7.04M Buy
369,403
+77,023
+26% +$1.18M 1.15% 11
2017
Q2 		$4.42M Sell
292,380
-224,560
-43% -$3.39M 0.7% 13
2017
Q1 		$8.87M Buy
+516,940
New +$6.89M 1.38% 12

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Oracle Investment Management's EPZM Position: Q4 2018 in Review

Oracle Investment Management sold out of Epizyme, Inc (EPZM) in Q4 2018, closing a stake of 28,884 shares — an estimated $306K sold.

Oracle Investment Management first reported a position in EPZM in Q1 2017 and held it in 7 quarters. The position peaked at $8.87M in Q1 2017. 105 funds tracked by Wall St. Rank hold EPZM as of Q4 2018.

  • Oracle Investment Management reported no remaining Epizyme, Inc position as of Q4 2018 after selling out during the quarter.
  • Oracle Investment Management sold 28,884 Epizyme, Inc shares in Q4 2018, an estimated $306K.
  • Oracle Investment Management first reported a position in Epizyme, Inc in Q1 2017 and held it in 7 quarters.
  • Oracle Investment Management's Epizyme, Inc position peaked at $8.87M in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2018.

Based on Oracle Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.